Answers are grounded in this paper and cite their sources.
Identifies a bidirectional feedback loop between brain Ang II/AT1R and MFG-E8/αvβ3 integrin signaling that regulates microglial efferocytosis and neuroinflammation resolution during aging, highlighting the Ang II–MFG-E8 axis and AT1R blockade (losartan) as potential therapeutic targets for neuroinflammation.
Aging is characterized by chronic low-grade inflammation, to which overactivation of the brain angiotensin II (Ang II)/AT1 receptor (AT1R) axis significantly contributes. Milk fat globule–EGF factor 8 (MFG-E8, lactadherin) promotes microglial efferocytosis and resolution of inflammation, but its interaction with AT1R signaling, particularly in the aging brain, remains unclear. We identify a bidirectional regulatory loop between Ang II/AT1R and MFG-E8/αvβ3 integrin pathways using neuronal–glial models and young and aged human and mouse brain tissue. Ang II/AT1R activation reduced MFG-E8 expression and impaired clearance of apoptotic neurons. Conversely, apoptotic signals and recombinant MFG-E8 suppressed AT1R expression and inflammatory signaling while enhancing pro-resolving pathways, involving NF-κB and STAT3 modulation. Aged brain tissue showed AT1R overactivation associated with reduced MFG-E8 expression. These findings reveal a previously unrecognized feedback interaction that limits resolution of neuroinflammation during aging, identifying the Ang II–MFG-E8 axis as a potential therapeutic target.
No takes yet. Share an insight, caveat, or question.
Rodriguez-Perez et al. (2026) studied Aging-related neuroinflammation. Angiotensin II, losartan, recombinant human MFG-E8 (rhMFG-E8), and apoptotic neuron conditioned media vs. Untreated control cells, viable neuron conditioned media, or wild-type/young brain tissue was evaluated on MFG-E8 and AT1R mRNA/protein expression and microglial phagocytic clearance of apoptotic neurons (p=<0.05).
Synapse has enriched 10 related papers. Consider them for comparative context: